ClinicalThought
View More
Patient perspectives and key action items to address in clinical settings to reduce HBV care barriers in the United States, from Clinical Care Options (CCO)
Clinical Care Options (CCO) commentary from Dr Carla Coffin on risks vs benefits of treating patients in the indeterminate category for HBV treatment
Clinical Care Options (CCO) commentary with advice for healthcare professionals from a person who had end-stage liver failure from a missed HCV diagnosis
Clinical Care Options (CCO) commentary from Maria Buti, MD, on the interplay between HBV infection and pregnancy
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.